Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DRUG compared with RLMD: revenue, margins and what each company keeps, and the suppliers and customers both name
DRUG
Bright Minds Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
RLMD
Relmada Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DRUG
Bright Minds Biosciences Inc.
vs
RLMD
Relmada Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
DRUG, solid
RLMD, dashed
DRUG
Bright Minds Biosciences Inc.
Change
22.87
▲
+10.48%
· post 22.66
Mkt cap
$175.6M
RLMD
Relmada Therapeutics, Inc.
Change
3.91
▲
+3.58%
· post 3.91
Closed
Nov 6 '26
Mkt cap
$438.3M
vs
Compare
Closed
Nov 6 '26
DRUG
Bright Minds Biosciences Inc.
vs
RLMD
Relmada Therapeutics, Inc.
22.87
▲
+10.48%
post 22.66
Price
3.91
▲
+3.58%
post 3.91
$175.6M
Mkt cap
$438.3M
Change
Change
DRUG
22.87
▲
+10.48%
vs
RLMD
3.91
▲
+3.58%
Closed
Nov 6 '26